Dong-A Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1932-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.dapharm.com
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02058472
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01941199
- Locations
- 🇰🇷
Clinical Trial Center, Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration
- First Posted Date
- 2013-08-27
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01929213
- Locations
- 🇰🇷
Severance Hospital Clinical Trial Center, Seoul, Korea, Republic of
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2013-08-26
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01928563
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-08-14
- Last Posted Date
- 2013-08-14
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 411
- Registration Number
- NCT01922375
- Locations
- 🇰🇷
Chonnam national university hospital, Gwangju, Korea, Republic of
Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction
- First Posted Date
- 2013-07-17
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 302
- Registration Number
- NCT01901640
A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-10
- Last Posted Date
- 2013-05-16
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT01851512
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT01820715
- Locations
- 🇰🇷
Hanyang University Medical Center, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 492
- Registration Number
- NCT01813812
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Target Recruit Count
- 220
- Registration Number
- NCT01798667
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath